Proton or Photon RT for Retroperitoneal Sarcomas
NCT01659203
This study is recruiting at 10 US sites in 8 states, according to its ClinicalTrials.gov record last updated .
Summary
This research study is a Phase I clinical trial. Phase I clinical trials test the safety of an investigational intervention. Phase I studies also try to define the appropriate dose of the investigational therapy to use for further studies. "Investigational" means that the intervention is still being studied and that research doctors are trying to find out more about it. Retroperitoneal sarcomas are soft tissue tumors located at the far back of the abdomen.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Retroperitoneal Sarcoma
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1/2
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Massachusetts General Hospital
- Last updated on ClinicalTrials.gov
- July 31, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Illinois · 1
- Rush University Medical Center · Chicago, IL
Massachusetts · 2
- Dana-Farber Cancer Institute · Boston, MA
- Massachusetts General Hospital · Boston, MA
Minnesota · 1
- Mayo Clinic · Rochester, MN
Missouri · 2
- Washington University School of Medicine Siteman Cancer Center West County · Creve Coeur, MO
- Washington University School of Medicine Siteman Cancer Center South County · St Louis, MO
New York · 1
- Roswell Park Cancer Institute · Buffalo, NY
North Carolina · 1
- Duke University · Durham, NC
Texas · 1
- MD Anderson Cancer Center · Houston, TX
Utah · 1
- University of Utah · Salt Lake City, UT
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.